CVS * Stock Overview
Provides health solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1,090.00 |
| 52 Week High | US$1,400.00 |
| 52 Week Low | US$890.01 |
| Beta | 0.54 |
| 11 Month Change | -9.17% |
| 3 Month Change | -1.00% |
| 1 Year Change | -8.26% |
| 33 Year Change | -44.25% |
| 5 Year Change | -26.40% |
| Change since IPO | 174.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVS * | MX Healthcare | MX Market | |
|---|---|---|---|
| 7D | -3.5% | 0.3% | -1.6% |
| 1Y | -8.3% | -13.6% | -3.1% |
Return vs Industry: CVS * exceeded the MX Healthcare industry which returned -13.6% over the past year.
Return vs Market: CVS * underperformed the MX Market which returned -3.1% over the past year.
Price Volatility
| CVS * volatility | |
|---|---|
| CVS * Average Weekly Movement | 5.5% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.2% |
| 10% least volatile stocks in MX Market | 2.6% |
Stable Share Price: CVS *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: CVS *'s weekly volatility (6%) has been stable over the past year, but is still higher than 75% of MX stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS * fundamental statistics | |
|---|---|
| Market cap | Mex$1.36t |
| Earnings (TTM) | Mex$102.27b |
| Revenue (TTM) | Mex$7.49t |
13.3x
P/E Ratio0.2x
P/S RatioIs CVS * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS * income statement (TTM) | |
|---|---|
| Revenue | US$367.25b |
| Cost of Revenue | US$316.53b |
| Gross Profit | US$50.71b |
| Other Expenses | US$45.70b |
| Earnings | US$5.02b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.99 |
| Gross Margin | 13.81% |
| Net Profit Margin | 1.37% |
| Debt/Equity Ratio | 85.4% |
How did CVS * perform over the long term?
See historical performance and comparison